Dishman Carbogen Amcis Limited Total Liabilities
Dishman Carbogen Amcis Limited total liabilities. Based on the latest financial reports, Dishman Carbogen Amcis Limited (DCAL) has total liabilities worth Rs47.44 Billion INR (≈ $513.07 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check DCAL financial resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Dishman Carbogen Amcis Limited (2005–2025)
Total liabilities of Dishman Carbogen Amcis Limited from 2005 to 2025. This chart illustrates how Dishman Carbogen Amcis Limited's total liabilities have evolved over time, based on quarterly financial data. Explore how much of Dishman Carbogen Amcis Limited's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Dishman Carbogen Amcis Limited Competitors by Total Liabilities
The table below lists competitors of Dishman Carbogen Amcis Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ouro Fino Saúde Animal Participações S.A
SA:OFSA3
|
Brazil | R$814.35 Million |
|
Shanghai Kaytune Industrial Co.Ltd
SHE:301001
|
China | CN¥87.89 Million |
|
LCY Technology Corp
TW:4989
|
Taiwan | NT$595.60 Million |
|
Bonduelle S.C.A.
PA:BON
|
France | €1.47 Billion |
|
HomeStreet Inc
NASDAQ:HMST
|
USA | $7.21 Billion |
|
Hangzhou Hopechart Iot Technology
SHG:688288
|
China | CN¥482.82 Million |
|
Drugs Made In America Acquisition Corp. Ordinary Shares
NASDAQ:DMAA
|
USA | $9.14 Million |
Liability Composition Analysis (2005–2025)
This chart breaks down Dishman Carbogen Amcis Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Dishman Carbogen Amcis Limited total assets.
Liquidity & Leverage Metrics
Dishman Carbogen Amcis Limited Total Liabilities Ratios Explained
Dishman Carbogen Amcis Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.10 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.28 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.75 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.43 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Dishman Carbogen Amcis Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Dishman Carbogen Amcis Limited (2005–2025)
The table below shows the annual total liabilities of Dishman Carbogen Amcis Limited from 2005 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs41.68 Billion ≈ $450.71 Million |
+5.41% |
| 2024-03-31 | Rs39.54 Billion ≈ $427.60 Million |
+8.51% |
| 2023-03-31 | Rs36.44 Billion ≈ $394.07 Million |
+17.98% |
| 2022-03-31 | Rs30.89 Billion ≈ $334.01 Million |
+15.79% |
| 2021-03-31 | Rs26.67 Billion ≈ $288.46 Million |
+7.35% |
| 2020-03-31 | Rs24.85 Billion ≈ $268.72 Million |
+27.46% |
| 2019-03-31 | Rs19.49 Billion ≈ $210.82 Million |
-5.79% |
| 2018-03-31 | Rs20.69 Billion ≈ $223.77 Million |
+16.28% |
| 2017-03-31 | Rs17.79 Billion ≈ $192.44 Million |
+16.42% |
| 2016-03-31 | Rs15.29 Billion ≈ $165.31 Million |
-2.71% |
| 2015-03-31 | Rs15.71 Billion ≈ $169.91 Million |
+14.10% |
| 2014-03-31 | Rs13.77 Billion ≈ $148.92 Million |
+9.26% |
| 2013-03-31 | Rs12.60 Billion ≈ $136.30 Million |
-4.53% |
| 2012-03-31 | Rs13.20 Billion ≈ $142.77 Million |
+9.72% |
| 2011-03-31 | Rs12.03 Billion ≈ $130.11 Million |
+19.35% |
| 2010-03-31 | Rs10.08 Billion ≈ $109.02 Million |
+2.37% |
| 2009-03-31 | Rs9.85 Billion ≈ $106.50 Million |
+9.89% |
| 2008-03-31 | Rs8.96 Billion ≈ $96.92 Million |
+6.32% |
| 2007-03-31 | Rs8.43 Billion ≈ $91.16 Million |
+107.07% |
| 2006-03-31 | Rs4.07 Billion ≈ $44.02 Million |
+132.48% |
| 2005-03-31 | Rs1.75 Billion ≈ $18.94 Million |
-- |
About Dishman Carbogen Amcis Limited
Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical and healthcare industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It offers cholesterol and vitamin D analogs; generic active pharmaceutical ingredients for diagnostics, ophthalmic treatments, laxatives, organop… Read more